Healthcare, Financials Jun 26, 2022 07:04 PM (GMT+8) · EqualOcean
Anglikang announced that according to the actual situation of the company, the company plans to give up the preemptive right to increase capital of the joint-stock company Hunan xinhexin biomedical Co., Ltd. (hereinafter referred to as "xinhexin"). After giving up the preemptive right of capital increase, the proportion of equity held by the company in xinhexin will be reduced from 12.55% to 11.16%.